Arcus Biosciences (RCUS) Cash from Investing Activities (QoQ) (2017 - 2026)
Arcus Biosciences (RCUS) Cash from Investing Activities (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Arcus Biosciences | 3.57 Bn | 2.75 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 162.64% |
| Dec 31, 2025 | -330.38% |
| Sep 30, 2025 | -42.34% |
| Jun 30, 2025 | 328.13% |
| Mar 31, 2025 | -37.25% |
| Dec 31, 2024 | 275.86% |
| Sep 30, 2024 | -146.03% |
| Jun 30, 2024 | 137.28% |
| Mar 31, 2024 | -703.57% |
| Dec 31, 2023 | 154.55% |
| Sep 30, 2023 | -57.69% |
| Jun 30, 2023 | -79.84% |
| Mar 31, 2023 | 174.47% |
| Dec 31, 2022 | 104.35% |
| Sep 30, 2022 | 110.70% |
| Jun 30, 2022 | 19.78% |
| Mar 31, 2022 | -1,526.90% |
| Dec 31, 2021 | 121.20% |
| Sep 30, 2021 | -3,050.75% |
| Jun 30, 2021 | -95.22% |